BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11146820)

  • 1. Transient and controllable opening of the blood-brain barrier to cytostatic and antibiotic agents by alkylglycerols in rats.
    Erdlenbruch B; Jendrossek V; Eibl H; Lakomek M
    Exp Brain Res; 2000 Dec; 135(3):417-22. PubMed ID: 11146820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.
    Erdlenbruch B; Alipour M; Fricker G; Miller DS; Kugler W; Eibl H; Lakomek M
    Br J Pharmacol; 2003 Dec; 140(7):1201-10. PubMed ID: 14597599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
    Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.
    Erdlenbruch B; Schinkhof C; Kugler W; Heinemann DE; Herms J; Eibl H; Lakomek M
    Br J Pharmacol; 2003 Jun; 139(4):685-94. PubMed ID: 12812991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier opening with alkylglycerols: Biodistribution of 1-O-pentylglycerol after intravenous and intracarotid administration in rats.
    Erdlenbruch B; Kugler W; Schinkhof C; Neurath H; Eibl H; Lakomek M
    J Drug Target; 2005 Apr; 13(3):143-50. PubMed ID: 16036302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
    Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
    Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
    Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.
    Neuwelt EA; Barnett PA; Bigner DD; Frenkel EP
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4420-3. PubMed ID: 6289301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene E4 selectively increase the delivery of methotrexate to the C6 gliomas in rats.
    Chio CC; Lin SJ; Lin MT
    J Neurooncol; 1995; 25(2):89-95. PubMed ID: 8543974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.
    Tokunaga Y; Nakashima M; Sasaki H; Tomiyama N; Nakashima MN; Ichikawa M; Kaminogo M; Shibata S
    Biol Pharm Bull; 2000 Dec; 23(12):1491-6. PubMed ID: 11145184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: observations on problems of drug delivery.
    Neuwelt EA; Barnett PA; Frenkel EP
    Neurosurgery; 1984 Feb; 14(2):154-60. PubMed ID: 6200798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification and pharmacokinetics of blood-brain barrier disruption in humans.
    Zünkeler B; Carson RE; Olson J; Blasberg RG; DeVroom H; Lutz RJ; Saris SC; Wright DC; Kammerer W; Patronas NJ; Dedrick RL; Herscovitch P; Oldfield EH
    J Neurosurg; 1996 Dec; 85(6):1056-65. PubMed ID: 8929495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
    Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
    Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers.
    Kroll RA; Pagel MA; Muldoon LL; Roman-Goldstein S; Fiamengo SA; Neuwelt EA
    Neurosurgery; 1998 Oct; 43(4):879-86; discussion 886-9. PubMed ID: 9766316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma.
    Nakashima M; Shibata S; Tokunaga Y; Fujita H; Anda T; Arizono K; Tomiyama N; Sasaki H; Ichikawa M
    J Pharm Pharmacol; 1997 Aug; 49(8):777-80. PubMed ID: 9379355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas.
    Weyerbrock A; Walbridge S; Pluta RM; Saavedra JE; Keefer LK; Oldfield EH
    J Neurosurg; 2003 Oct; 99(4):728-37. PubMed ID: 14567609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
    Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
    Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.